Low-dose metronomic eribulin in metastatic breast cancer: Is this real metronomic therapy?

被引：0
|
作者：
Altundag, Kadri [1 ]
机构：
[1] MKA Breast Canc Clin, Ankara, Turkey
来源：
JOURNAL OF BUON | 2021年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1174 / 1174
页数：1
相关论文
共 50 条
  • [41] Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer
    Hiroshi Kikuchi
    Nako Maishi
    Li Yu
    Zi Jia
    Cong Li
    Masumi Sato
    Ryo Takeda
    Keita Ishizuka
    Yasuhiro Hida
    Nobuo Shinohara
    Kyoko Hida
    British Journal of Cancer, 2024, 130 : 336 - 345
  • [42] Low-dose metronomic oral cyclophosphamide plus prednisone for metastatic castration resistant prostate cancer (mCRPC) patients
    Martinez Lago, N.
    Anido, U.
    Vieito, M.
    Varela-Ponte, R.
    Carmona, M.
    Rodriguez, C.
    Cortegoso, A.
    Candamio, S.
    Lopez-Lopez, R.
    Leon, L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S705 - S706
  • [43] Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer
    Kikuchi, Hiroshi
    Maishi, Nako
    Yu, Li
    Jia, Zi
    Li, Cong
    Sato, Masumi
    Takeda, Ryo
    Ishizuka, Keita
    Hida, Yasuhiro
    Shinohara, Nobuo
    Hida, Kyoko
    BRITISH JOURNAL OF CANCER, 2024, 130 (02) : 336 - 345
  • [44] Metronomic Chemotherapy as a Treatment Option for metastatic Breast Cancer
    Krajnak, S.
    Anic, K.
    Almstedt, K.
    Heimes, A-S
    Krajnakova, J.
    Linz, V
    Loewe, A.
    Hasenburg, A.
    Schmidt, M.
    Battista, M. J.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : E109 - E109
  • [45] Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer
    Saloustros, E.
    Kalbakis, K.
    Vardakis, N.
    Kalykaki, A.
    Milaki, G.
    Rovithi, M.
    Agelaki, S.
    Saridaki, Z.
    Georgoulias, V.
    Mavroudis, D.
    JOURNAL OF BUON, 2011, 16 (02): : 215 - 218
  • [46] Metronomic therapy and breast cancer: A systematic review
    Montagna, Emilia
    Cancello, Giuseppe
    Dellapasqua, Silvia
    Munzone, Elisabetta
    Colleoni, Marco
    CANCER TREATMENT REVIEWS, 2014, 40 (08) : 942 - 950
  • [47] Outcomes of patients with HER2 positive metastatic breast cancer treated with low dose or metronomic lapatinib
    Mathew, S. P.
    Avaronnan, M.
    Shenoy, P. K.
    Devi R, N.
    ANNALS OF ONCOLOGY, 2022, 33 : S1439 - S1439
  • [48] Low-Dose Metronomic Capecitabine (Xeloda) for Treatment of Metastatic Cholangiocarcinoma : Case Reports and Review of the Literature
    Bjornsson, Bergthor
    Albertsson, Maria
    Sandstrom, Per
    JOURNAL OF THE PANCREAS, 2016, 17 (06): : 587 - 591
  • [49] SAFETY AND EFFICACY OF LOW DOSE METRONOMIC CHEMOTHERAPY WITH CAPECITABINE IN HEAVILY PRETREATED METASTATIC BREAST CANCER (MBC) PATIENTS
    Fedele, P.
    Orlando, L.
    Schiavone, P.
    Rizzo, P.
    Calvani, N.
    Marino, A.
    D'Amico, M.
    Sponziello, F.
    Nacci, A.
    Mazzoni, E.
    Chetri, M. C.
    Cinefra, M.
    Cinieri, S.
    CANCER TREATMENT REVIEWS, 2010, 36 : S100 - S100
  • [50] Low-dose metronomic chemotherapy (LDMC) as an efficient treatment option in metastatic breast cancer: Results of an exploratory case-control study.
    Battista, Marco Johannes
    Schnatz, Carola
    Almstedt, Katrin
    Brenner, Walburgis
    Heimes, Anne-Sophie
    Nezi-Cahn, Sandra
    Schwab, Roxana
    Hasenburg, Annette
    Schmidt, Marcus
    Krajnak, Slavomir
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345